Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank A Post

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
AIDS (London, England)|January 26, 2026
Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutationGraeme Moyle, Lambert Assoumou, Nathalie De Castro, et al.
AIDS (London, England)|August 11, 2020
The predictors of pain extent in people living with HIVCaroline A Sabin, Richard Harding, Emmanouil Bagkeris, et al.
British Journal of Clinical Pharmacology|February 9, 2024
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South AfricaRephaim Mpofu, Aida N Kawuma, Roeland E Wasmann, et al.
The Journal of Infection|November 20, 2013
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern EuropeFrank A Post, Daniel Grint, Anne Marie Werlinrud, et al.
Open Forum Infectious Diseases|January 15, 2021
Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) StudyKen M Kunisaki, Davide De Francesco, Caroline A Sabin, et al.
International Journal of Epidemiology|May 11, 2018
Cohort profile: The Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) studyEmmanouil Bagkeris, Laura Burgess, Patrick W Mallon, et al.
Kidney International|February 6, 2018
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R Swanepoel, Mohamed G Atta, Vivette D D'Agati, et al.
Kidney International Reports|July 1, 2026
<i>APOL1</i> Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIVRachel K Y Hung, John W Booth, Rachel Hilton, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
AIDS (London, England)|January 26, 2026
Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutationGraeme Moyle, Lambert Assoumou, Nathalie De Castro, et al.
AIDS (London, England)|August 11, 2020
The predictors of pain extent in people living with HIVCaroline A Sabin, Richard Harding, Emmanouil Bagkeris, et al.
British Journal of Clinical Pharmacology|February 9, 2024
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South AfricaRephaim Mpofu, Aida N Kawuma, Roeland E Wasmann, et al.
The Journal of Infection|November 20, 2013
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern EuropeFrank A Post, Daniel Grint, Anne Marie Werlinrud, et al.
Open Forum Infectious Diseases|January 15, 2021
Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) StudyKen M Kunisaki, Davide De Francesco, Caroline A Sabin, et al.
International Journal of Epidemiology|May 11, 2018
Cohort profile: The Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) studyEmmanouil Bagkeris, Laura Burgess, Patrick W Mallon, et al.
Kidney International|February 6, 2018
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R Swanepoel, Mohamed G Atta, Vivette D D'Agati, et al.
Kidney International Reports|July 1, 2026
<i>APOL1</i> Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIVRachel K Y Hung, John W Booth, Rachel Hilton, et al.
Pageof 18